nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—Ketoprofen—CXCL8—pancreatic cancer	0.00213	0.369	CrCbGaD
Labetalol—Salsalate—PTGS2—pancreatic cancer	0.00127	0.221	CrCbGaD
Labetalol—Hypoglycaemia—Epirubicin—pancreatic cancer	0.00113	0.00141	CcSEcCtD
Labetalol—Cardiac failure—Epirubicin—pancreatic cancer	0.00113	0.00141	CcSEcCtD
Labetalol—Diarrhoea—Tamoxifen—pancreatic cancer	0.00112	0.00141	CcSEcCtD
Labetalol—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00112	0.00141	CcSEcCtD
Labetalol—Lethargy—Epirubicin—pancreatic cancer	0.00112	0.00141	CcSEcCtD
Labetalol—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00112	0.0014	CcSEcCtD
Labetalol—Confusional state—Fluorouracil—pancreatic cancer	0.00112	0.0014	CcSEcCtD
Labetalol—Body temperature increased—Sunitinib—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Abdominal pain—Sunitinib—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Diarrhoea—Erlotinib—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Oedema peripheral—Docetaxel—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Oedema—Fluorouracil—pancreatic cancer	0.00111	0.00139	CcSEcCtD
Labetalol—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00109	0.00137	CcSEcCtD
Labetalol—Visual impairment—Docetaxel—pancreatic cancer	0.00109	0.00136	CcSEcCtD
Labetalol—Dizziness—Tamoxifen—pancreatic cancer	0.00109	0.00136	CcSEcCtD
Labetalol—Hypotension—Irinotecan—pancreatic cancer	0.00108	0.00136	CcSEcCtD
Labetalol—Affect lability—Epirubicin—pancreatic cancer	0.00108	0.00136	CcSEcCtD
Labetalol—Dizziness—Erlotinib—pancreatic cancer	0.00107	0.00135	CcSEcCtD
Labetalol—Hypotension—Gemcitabine—pancreatic cancer	0.00105	0.00132	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—pancreatic cancer	0.00105	0.183	CrCbGaD
Labetalol—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00105	0.00132	CcSEcCtD
Labetalol—Flushing—Docetaxel—pancreatic cancer	0.00105	0.00131	CcSEcCtD
Labetalol—Vomiting—Tamoxifen—pancreatic cancer	0.00104	0.00131	CcSEcCtD
Labetalol—Cardiac failure—Doxorubicin—pancreatic cancer	0.00104	0.00131	CcSEcCtD
Labetalol—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00104	0.00131	CcSEcCtD
Labetalol—Mood swings—Epirubicin—pancreatic cancer	0.00104	0.00131	CcSEcCtD
Labetalol—Paraesthesia—Irinotecan—pancreatic cancer	0.00104	0.0013	CcSEcCtD
Labetalol—Lethargy—Doxorubicin—pancreatic cancer	0.00104	0.0013	CcSEcCtD
Labetalol—Hypotension—Fluorouracil—pancreatic cancer	0.00104	0.0013	CcSEcCtD
Labetalol—Hypersensitivity—Sunitinib—pancreatic cancer	0.00104	0.0013	CcSEcCtD
Labetalol—Rash—Tamoxifen—pancreatic cancer	0.00103	0.0013	CcSEcCtD
Labetalol—Dermatitis—Tamoxifen—pancreatic cancer	0.00103	0.0013	CcSEcCtD
Labetalol—Vomiting—Erlotinib—pancreatic cancer	0.00103	0.0013	CcSEcCtD
Labetalol—Dyspnoea—Irinotecan—pancreatic cancer	0.00103	0.0013	CcSEcCtD
Labetalol—Somnolence—Irinotecan—pancreatic cancer	0.00103	0.00129	CcSEcCtD
Labetalol—Headache—Tamoxifen—pancreatic cancer	0.00103	0.00129	CcSEcCtD
Labetalol—Rash—Erlotinib—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Labetalol—Dermatitis—Erlotinib—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Labetalol—Dyspepsia—Irinotecan—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Labetalol—Headache—Erlotinib—pancreatic cancer	0.00102	0.00128	CcSEcCtD
Labetalol—Liver function test abnormal—Epirubicin—pancreatic cancer	0.00101	0.00127	CcSEcCtD
Labetalol—Paraesthesia—Gemcitabine—pancreatic cancer	0.00101	0.00127	CcSEcCtD
Labetalol—Asthenia—Sunitinib—pancreatic cancer	0.00101	0.00127	CcSEcCtD
Labetalol—Dyspnoea—Gemcitabine—pancreatic cancer	0.00101	0.00126	CcSEcCtD
Labetalol—Abdominal pain upper—Epirubicin—pancreatic cancer	0.001	0.00126	CcSEcCtD
Labetalol—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.001	0.00126	CcSEcCtD
Labetalol—Somnolence—Gemcitabine—pancreatic cancer	0.001	0.00126	CcSEcCtD
Labetalol—Affect lability—Doxorubicin—pancreatic cancer	0.001	0.00126	CcSEcCtD
Labetalol—Fatigue—Irinotecan—pancreatic cancer	0.000998	0.00125	CcSEcCtD
Labetalol—Paraesthesia—Fluorouracil—pancreatic cancer	0.000996	0.00125	CcSEcCtD
Labetalol—Alopecia—Docetaxel—pancreatic cancer	0.000995	0.00125	CcSEcCtD
Labetalol—Pruritus—Sunitinib—pancreatic cancer	0.000994	0.00125	CcSEcCtD
Labetalol—Constipation—Irinotecan—pancreatic cancer	0.00099	0.00124	CcSEcCtD
Labetalol—Pain—Irinotecan—pancreatic cancer	0.00099	0.00124	CcSEcCtD
Labetalol—Dyspnoea—Fluorouracil—pancreatic cancer	0.000989	0.00124	CcSEcCtD
Labetalol—Mental disorder—Docetaxel—pancreatic cancer	0.000987	0.00124	CcSEcCtD
Labetalol—Somnolence—Fluorouracil—pancreatic cancer	0.000986	0.00124	CcSEcCtD
Labetalol—Erythema—Docetaxel—pancreatic cancer	0.000981	0.00123	CcSEcCtD
Labetalol—Dyspepsia—Fluorouracil—pancreatic cancer	0.000976	0.00123	CcSEcCtD
Labetalol—Nausea—Tamoxifen—pancreatic cancer	0.000975	0.00122	CcSEcCtD
Labetalol—Fatigue—Gemcitabine—pancreatic cancer	0.000972	0.00122	CcSEcCtD
Labetalol—Pain—Gemcitabine—pancreatic cancer	0.000964	0.00121	CcSEcCtD
Labetalol—Constipation—Gemcitabine—pancreatic cancer	0.000964	0.00121	CcSEcCtD
Labetalol—Nausea—Erlotinib—pancreatic cancer	0.000964	0.00121	CcSEcCtD
Labetalol—Mood swings—Doxorubicin—pancreatic cancer	0.000963	0.00121	CcSEcCtD
Labetalol—Diarrhoea—Sunitinib—pancreatic cancer	0.000962	0.00121	CcSEcCtD
Labetalol—Feeling abnormal—Irinotecan—pancreatic cancer	0.000954	0.0012	CcSEcCtD
Labetalol—Pain—Fluorouracil—pancreatic cancer	0.000948	0.00119	CcSEcCtD
Labetalol—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000947	0.00119	CcSEcCtD
Labetalol—Muscle spasms—Docetaxel—pancreatic cancer	0.000943	0.00118	CcSEcCtD
Labetalol—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000938	0.00118	CcSEcCtD
Labetalol—Dizziness—Sunitinib—pancreatic cancer	0.000929	0.00117	CcSEcCtD
Labetalol—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000929	0.00117	CcSEcCtD
Labetalol—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000928	0.00116	CcSEcCtD
Labetalol—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000928	0.00116	CcSEcCtD
Labetalol—Angina pectoris—Epirubicin—pancreatic cancer	0.000925	0.00116	CcSEcCtD
Labetalol—Body temperature increased—Irinotecan—pancreatic cancer	0.000915	0.00115	CcSEcCtD
Labetalol—Abdominal pain—Irinotecan—pancreatic cancer	0.000915	0.00115	CcSEcCtD
Labetalol—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000914	0.00115	CcSEcCtD
Labetalol—Vomiting—Sunitinib—pancreatic cancer	0.000894	0.00112	CcSEcCtD
Labetalol—Body temperature increased—Gemcitabine—pancreatic cancer	0.000892	0.00112	CcSEcCtD
Labetalol—Dysuria—Epirubicin—pancreatic cancer	0.000888	0.00111	CcSEcCtD
Labetalol—Rash—Sunitinib—pancreatic cancer	0.000886	0.00111	CcSEcCtD
Labetalol—Dermatitis—Sunitinib—pancreatic cancer	0.000885	0.00111	CcSEcCtD
Labetalol—Urticaria—Fluorouracil—pancreatic cancer	0.000881	0.00111	CcSEcCtD
Labetalol—Headache—Sunitinib—pancreatic cancer	0.000881	0.00111	CcSEcCtD
Labetalol—Syncope—Docetaxel—pancreatic cancer	0.000879	0.0011	CcSEcCtD
Labetalol—Body temperature increased—Fluorouracil—pancreatic cancer	0.000877	0.0011	CcSEcCtD
Labetalol—Palpitations—Docetaxel—pancreatic cancer	0.000867	0.00109	CcSEcCtD
Labetalol—Loss of consciousness—Docetaxel—pancreatic cancer	0.000862	0.00108	CcSEcCtD
Labetalol—Angina pectoris—Doxorubicin—pancreatic cancer	0.000856	0.00107	CcSEcCtD
Labetalol—Hypersensitivity—Irinotecan—pancreatic cancer	0.000853	0.00107	CcSEcCtD
Labetalol—Hypertension—Docetaxel—pancreatic cancer	0.000847	0.00106	CcSEcCtD
Labetalol—Drowsiness—Epirubicin—pancreatic cancer	0.000846	0.00106	CcSEcCtD
Labetalol—Nausea—Sunitinib—pancreatic cancer	0.000835	0.00105	CcSEcCtD
Labetalol—Asthenia—Irinotecan—pancreatic cancer	0.000831	0.00104	CcSEcCtD
Labetalol—Jaundice—Epirubicin—pancreatic cancer	0.000825	0.00104	CcSEcCtD
Labetalol—Dysuria—Doxorubicin—pancreatic cancer	0.000821	0.00103	CcSEcCtD
Labetalol—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000817	0.00103	CcSEcCtD
Labetalol—Sweating—Epirubicin—pancreatic cancer	0.000811	0.00102	CcSEcCtD
Labetalol—Asthenia—Gemcitabine—pancreatic cancer	0.000809	0.00102	CcSEcCtD
Labetalol—Confusional state—Docetaxel—pancreatic cancer	0.000807	0.00101	CcSEcCtD
Labetalol—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0008	0.001	CcSEcCtD
Labetalol—Oedema—Docetaxel—pancreatic cancer	0.0008	0.001	CcSEcCtD
Labetalol—Epistaxis—Epirubicin—pancreatic cancer	0.000798	0.001	CcSEcCtD
Labetalol—Pruritus—Gemcitabine—pancreatic cancer	0.000798	0.001	CcSEcCtD
Labetalol—Diarrhoea—Irinotecan—pancreatic cancer	0.000792	0.000994	CcSEcCtD
Labetalol—Agranulocytosis—Epirubicin—pancreatic cancer	0.00079	0.000991	CcSEcCtD
Labetalol—Shock—Docetaxel—pancreatic cancer	0.000787	0.000988	CcSEcCtD
Labetalol—Pruritus—Fluorouracil—pancreatic cancer	0.000785	0.000985	CcSEcCtD
Labetalol—Drowsiness—Doxorubicin—pancreatic cancer	0.000783	0.000983	CcSEcCtD
Labetalol—Bradycardia—Epirubicin—pancreatic cancer	0.000774	0.000971	CcSEcCtD
Labetalol—Diarrhoea—Gemcitabine—pancreatic cancer	0.000772	0.000968	CcSEcCtD
Labetalol—Dizziness—Irinotecan—pancreatic cancer	0.000766	0.000961	CcSEcCtD
Labetalol—Jaundice—Doxorubicin—pancreatic cancer	0.000763	0.000958	CcSEcCtD
Labetalol—Hepatitis—Epirubicin—pancreatic cancer	0.00076	0.000954	CcSEcCtD
Labetalol—Diarrhoea—Fluorouracil—pancreatic cancer	0.000759	0.000952	CcSEcCtD
Labetalol—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000756	0.000949	CcSEcCtD
Labetalol—Sweating—Doxorubicin—pancreatic cancer	0.000751	0.000942	CcSEcCtD
Labetalol—Oedema peripheral—Epirubicin—pancreatic cancer	0.000749	0.000939	CcSEcCtD
Labetalol—Hypotension—Docetaxel—pancreatic cancer	0.000748	0.000939	CcSEcCtD
Labetalol—Epistaxis—Doxorubicin—pancreatic cancer	0.000739	0.000927	CcSEcCtD
Labetalol—Vomiting—Irinotecan—pancreatic cancer	0.000736	0.000924	CcSEcCtD
Labetalol—Dizziness—Fluorouracil—pancreatic cancer	0.000733	0.00092	CcSEcCtD
Labetalol—Visual impairment—Epirubicin—pancreatic cancer	0.000732	0.000919	CcSEcCtD
Labetalol—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000731	0.000917	CcSEcCtD
Labetalol—Rash—Irinotecan—pancreatic cancer	0.00073	0.000916	CcSEcCtD
Labetalol—Dermatitis—Irinotecan—pancreatic cancer	0.000729	0.000915	CcSEcCtD
Labetalol—Headache—Irinotecan—pancreatic cancer	0.000725	0.00091	CcSEcCtD
Labetalol—Paraesthesia—Docetaxel—pancreatic cancer	0.000719	0.000902	CcSEcCtD
Labetalol—Vomiting—Gemcitabine—pancreatic cancer	0.000717	0.0009	CcSEcCtD
Labetalol—Bradycardia—Doxorubicin—pancreatic cancer	0.000716	0.000898	CcSEcCtD
Labetalol—Dyspnoea—Docetaxel—pancreatic cancer	0.000714	0.000896	CcSEcCtD
Labetalol—Somnolence—Docetaxel—pancreatic cancer	0.000711	0.000893	CcSEcCtD
Labetalol—Rash—Gemcitabine—pancreatic cancer	0.000711	0.000892	CcSEcCtD
Labetalol—Dermatitis—Gemcitabine—pancreatic cancer	0.00071	0.000892	CcSEcCtD
Labetalol—Headache—Gemcitabine—pancreatic cancer	0.000707	0.000887	CcSEcCtD
Labetalol—Flushing—Epirubicin—pancreatic cancer	0.000705	0.000885	CcSEcCtD
Labetalol—Vomiting—Fluorouracil—pancreatic cancer	0.000705	0.000885	CcSEcCtD
Labetalol—Dyspepsia—Docetaxel—pancreatic cancer	0.000704	0.000884	CcSEcCtD
Labetalol—Hepatitis—Doxorubicin—pancreatic cancer	0.000703	0.000882	CcSEcCtD
Labetalol—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.0007	0.000878	CcSEcCtD
Labetalol—Rash—Fluorouracil—pancreatic cancer	0.000699	0.000878	CcSEcCtD
Labetalol—Dermatitis—Fluorouracil—pancreatic cancer	0.000699	0.000877	CcSEcCtD
Labetalol—Headache—Fluorouracil—pancreatic cancer	0.000695	0.000872	CcSEcCtD
Labetalol—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000693	0.000869	CcSEcCtD
Labetalol—Fatigue—Docetaxel—pancreatic cancer	0.00069	0.000866	CcSEcCtD
Labetalol—Nausea—Irinotecan—pancreatic cancer	0.000688	0.000863	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—pancreatic cancer	0.000686	0.119	CrCbGaD
Labetalol—Pain—Docetaxel—pancreatic cancer	0.000684	0.000859	CcSEcCtD
Labetalol—Constipation—Docetaxel—pancreatic cancer	0.000684	0.000859	CcSEcCtD
Labetalol—Visual impairment—Doxorubicin—pancreatic cancer	0.000678	0.00085	CcSEcCtD
Labetalol—Alopecia—Epirubicin—pancreatic cancer	0.000671	0.000843	CcSEcCtD
Labetalol—Nausea—Gemcitabine—pancreatic cancer	0.00067	0.000841	CcSEcCtD
Labetalol—Mental disorder—Epirubicin—pancreatic cancer	0.000666	0.000835	CcSEcCtD
Labetalol—Erythema—Epirubicin—pancreatic cancer	0.000661	0.00083	CcSEcCtD
Labetalol—Feeling abnormal—Docetaxel—pancreatic cancer	0.00066	0.000828	CcSEcCtD
Labetalol—Nausea—Fluorouracil—pancreatic cancer	0.000659	0.000827	CcSEcCtD
Labetalol—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000654	0.000821	CcSEcCtD
Labetalol—Flushing—Doxorubicin—pancreatic cancer	0.000652	0.000819	CcSEcCtD
Labetalol—Muscle spasms—Epirubicin—pancreatic cancer	0.000636	0.000798	CcSEcCtD
Labetalol—Abdominal pain—Docetaxel—pancreatic cancer	0.000633	0.000794	CcSEcCtD
Labetalol—Body temperature increased—Docetaxel—pancreatic cancer	0.000633	0.000794	CcSEcCtD
Labetalol—Vision blurred—Epirubicin—pancreatic cancer	0.000623	0.000782	CcSEcCtD
Labetalol—Alopecia—Doxorubicin—pancreatic cancer	0.000621	0.00078	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—pancreatic cancer	0.00062	0.108	CrCbGaD
Labetalol—Mental disorder—Doxorubicin—pancreatic cancer	0.000616	0.000773	CcSEcCtD
Labetalol—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000614	0.00077	CcSEcCtD
Labetalol—Erythema—Doxorubicin—pancreatic cancer	0.000612	0.000768	CcSEcCtD
Labetalol—Malaise—Epirubicin—pancreatic cancer	0.000596	0.000749	CcSEcCtD
Labetalol—Vertigo—Epirubicin—pancreatic cancer	0.000594	0.000746	CcSEcCtD
Labetalol—Syncope—Epirubicin—pancreatic cancer	0.000593	0.000744	CcSEcCtD
Labetalol—Hypersensitivity—Docetaxel—pancreatic cancer	0.00059	0.00074	CcSEcCtD
Labetalol—Muscle spasms—Doxorubicin—pancreatic cancer	0.000588	0.000739	CcSEcCtD
Labetalol—Palpitations—Epirubicin—pancreatic cancer	0.000585	0.000734	CcSEcCtD
Labetalol—Loss of consciousness—Epirubicin—pancreatic cancer	0.000581	0.00073	CcSEcCtD
Labetalol—Vision blurred—Doxorubicin—pancreatic cancer	0.000577	0.000724	CcSEcCtD
Labetalol—Asthenia—Docetaxel—pancreatic cancer	0.000574	0.000721	CcSEcCtD
Labetalol—Hypertension—Epirubicin—pancreatic cancer	0.000571	0.000717	CcSEcCtD
Labetalol—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000568	0.000713	CcSEcCtD
Labetalol—Pruritus—Docetaxel—pancreatic cancer	0.000566	0.000711	CcSEcCtD
Labetalol—Discomfort—Epirubicin—pancreatic cancer	0.000556	0.000698	CcSEcCtD
Labetalol—Malaise—Doxorubicin—pancreatic cancer	0.000552	0.000693	CcSEcCtD
Labetalol—Vertigo—Doxorubicin—pancreatic cancer	0.00055	0.00069	CcSEcCtD
Labetalol—Syncope—Doxorubicin—pancreatic cancer	0.000549	0.000689	CcSEcCtD
Labetalol—Diarrhoea—Docetaxel—pancreatic cancer	0.000548	0.000687	CcSEcCtD
Labetalol—Confusional state—Epirubicin—pancreatic cancer	0.000544	0.000683	CcSEcCtD
Labetalol—Palpitations—Doxorubicin—pancreatic cancer	0.000541	0.000679	CcSEcCtD
Labetalol—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00054	0.000678	CcSEcCtD
Labetalol—Oedema—Epirubicin—pancreatic cancer	0.00054	0.000678	CcSEcCtD
Labetalol—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000538	0.000675	CcSEcCtD
Labetalol—Shock—Epirubicin—pancreatic cancer	0.000531	0.000667	CcSEcCtD
Labetalol—Dizziness—Docetaxel—pancreatic cancer	0.000529	0.000664	CcSEcCtD
Labetalol—Hypertension—Doxorubicin—pancreatic cancer	0.000528	0.000663	CcSEcCtD
Labetalol—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000522	0.000655	CcSEcCtD
Labetalol—Discomfort—Doxorubicin—pancreatic cancer	0.000515	0.000646	CcSEcCtD
Labetalol—Vomiting—Docetaxel—pancreatic cancer	0.000509	0.000639	CcSEcCtD
Labetalol—Rash—Docetaxel—pancreatic cancer	0.000505	0.000633	CcSEcCtD
Labetalol—Hypotension—Epirubicin—pancreatic cancer	0.000504	0.000633	CcSEcCtD
Labetalol—Dermatitis—Docetaxel—pancreatic cancer	0.000504	0.000633	CcSEcCtD
Labetalol—Confusional state—Doxorubicin—pancreatic cancer	0.000504	0.000632	CcSEcCtD
Labetalol—Headache—Docetaxel—pancreatic cancer	0.000501	0.000629	CcSEcCtD
Labetalol—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000499	0.000627	CcSEcCtD
Labetalol—Oedema—Doxorubicin—pancreatic cancer	0.000499	0.000627	CcSEcCtD
Labetalol—Shock—Doxorubicin—pancreatic cancer	0.000491	0.000617	CcSEcCtD
Labetalol—Paraesthesia—Epirubicin—pancreatic cancer	0.000485	0.000608	CcSEcCtD
Labetalol—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000483	0.000606	CcSEcCtD
Labetalol—Dyspnoea—Epirubicin—pancreatic cancer	0.000481	0.000604	CcSEcCtD
Labetalol—Somnolence—Epirubicin—pancreatic cancer	0.00048	0.000602	CcSEcCtD
Labetalol—Nausea—Docetaxel—pancreatic cancer	0.000475	0.000597	CcSEcCtD
Labetalol—Dyspepsia—Epirubicin—pancreatic cancer	0.000475	0.000596	CcSEcCtD
Labetalol—Hypotension—Doxorubicin—pancreatic cancer	0.000467	0.000586	CcSEcCtD
Labetalol—Fatigue—Epirubicin—pancreatic cancer	0.000465	0.000584	CcSEcCtD
Labetalol—Pain—Epirubicin—pancreatic cancer	0.000462	0.000579	CcSEcCtD
Labetalol—Constipation—Epirubicin—pancreatic cancer	0.000462	0.000579	CcSEcCtD
Labetalol—Paraesthesia—Doxorubicin—pancreatic cancer	0.000449	0.000563	CcSEcCtD
Labetalol—Dyspnoea—Doxorubicin—pancreatic cancer	0.000445	0.000559	CcSEcCtD
Labetalol—Feeling abnormal—Epirubicin—pancreatic cancer	0.000445	0.000558	CcSEcCtD
Labetalol—Somnolence—Doxorubicin—pancreatic cancer	0.000444	0.000557	CcSEcCtD
Labetalol—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000441	0.000554	CcSEcCtD
Labetalol—Dyspepsia—Doxorubicin—pancreatic cancer	0.00044	0.000552	CcSEcCtD
Labetalol—Fatigue—Doxorubicin—pancreatic cancer	0.000431	0.00054	CcSEcCtD
Labetalol—Urticaria—Epirubicin—pancreatic cancer	0.000429	0.000538	CcSEcCtD
Labetalol—Pain—Doxorubicin—pancreatic cancer	0.000427	0.000536	CcSEcCtD
Labetalol—Constipation—Doxorubicin—pancreatic cancer	0.000427	0.000536	CcSEcCtD
Labetalol—Abdominal pain—Epirubicin—pancreatic cancer	0.000427	0.000536	CcSEcCtD
Labetalol—Body temperature increased—Epirubicin—pancreatic cancer	0.000427	0.000536	CcSEcCtD
Labetalol—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000412	0.000517	CcSEcCtD
Labetalol—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000408	0.000513	CcSEcCtD
Labetalol—Hypersensitivity—Epirubicin—pancreatic cancer	0.000398	0.000499	CcSEcCtD
Labetalol—Urticaria—Doxorubicin—pancreatic cancer	0.000397	0.000498	CcSEcCtD
Labetalol—Body temperature increased—Doxorubicin—pancreatic cancer	0.000395	0.000496	CcSEcCtD
Labetalol—Abdominal pain—Doxorubicin—pancreatic cancer	0.000395	0.000496	CcSEcCtD
Labetalol—Asthenia—Epirubicin—pancreatic cancer	0.000387	0.000486	CcSEcCtD
Labetalol—Pruritus—Epirubicin—pancreatic cancer	0.000382	0.000479	CcSEcCtD
Labetalol—Diarrhoea—Epirubicin—pancreatic cancer	0.000369	0.000464	CcSEcCtD
Labetalol—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000368	0.000462	CcSEcCtD
Labetalol—Asthenia—Doxorubicin—pancreatic cancer	0.000358	0.00045	CcSEcCtD
Labetalol—Dizziness—Epirubicin—pancreatic cancer	0.000357	0.000448	CcSEcCtD
Labetalol—Pruritus—Doxorubicin—pancreatic cancer	0.000353	0.000444	CcSEcCtD
Labetalol—Vomiting—Epirubicin—pancreatic cancer	0.000343	0.000431	CcSEcCtD
Labetalol—Diarrhoea—Doxorubicin—pancreatic cancer	0.000342	0.000429	CcSEcCtD
Labetalol—Rash—Epirubicin—pancreatic cancer	0.00034	0.000427	CcSEcCtD
Labetalol—Dermatitis—Epirubicin—pancreatic cancer	0.00034	0.000427	CcSEcCtD
Labetalol—Headache—Epirubicin—pancreatic cancer	0.000338	0.000424	CcSEcCtD
Labetalol—Dizziness—Doxorubicin—pancreatic cancer	0.00033	0.000415	CcSEcCtD
Labetalol—Nausea—Epirubicin—pancreatic cancer	0.000321	0.000402	CcSEcCtD
Labetalol—Vomiting—Doxorubicin—pancreatic cancer	0.000318	0.000399	CcSEcCtD
Labetalol—Rash—Doxorubicin—pancreatic cancer	0.000315	0.000395	CcSEcCtD
Labetalol—Dermatitis—Doxorubicin—pancreatic cancer	0.000315	0.000395	CcSEcCtD
Labetalol—Headache—Doxorubicin—pancreatic cancer	0.000313	0.000393	CcSEcCtD
Labetalol—Nausea—Doxorubicin—pancreatic cancer	0.000297	0.000372	CcSEcCtD
Labetalol—ADRB3—Signaling Pathways—PTHLH—pancreatic cancer	0.000197	0.000997	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTCH1—pancreatic cancer	0.000197	0.000997	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SSTR1—pancreatic cancer	0.000195	0.000987	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—SST—pancreatic cancer	0.000195	0.000986	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000193	0.000979	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000193	0.000979	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPY—pancreatic cancer	0.000191	0.000968	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000191	0.000966	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SSTR2—pancreatic cancer	0.000188	0.00095	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPY—pancreatic cancer	0.000187	0.000947	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000184	0.000931	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	0.000184	0.00093	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCKBR—pancreatic cancer	0.000181	0.000918	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—SST—pancreatic cancer	0.000181	0.000916	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00018	0.000913	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SST—pancreatic cancer	0.00018	0.000911	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	0.00018	0.00091	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000178	0.000899	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GCG—pancreatic cancer	0.000178	0.000899	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	0.000177	0.000898	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—SST—pancreatic cancer	0.000177	0.000896	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000176	0.000893	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JAG1—pancreatic cancer	0.000176	0.000892	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000175	0.000888	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	0.000174	0.000879	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—DTX4—pancreatic cancer	0.00017	0.000863	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GLI1—pancreatic cancer	0.00017	0.000863	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000169	0.000857	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CNR1—pancreatic cancer	0.000167	0.000845	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	0.000167	0.000844	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	0.000167	0.000844	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CNR1—pancreatic cancer	0.000166	0.000841	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NRP1—pancreatic cancer	0.000166	0.00084	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000166	0.00084	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000166	0.000839	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	0.000163	0.000827	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	0.000162	0.000821	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000162	0.000821	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000161	0.000816	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GCG—pancreatic cancer	0.000161	0.000816	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GCG—pancreatic cancer	0.00016	0.000812	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HEY2—pancreatic cancer	0.00016	0.000808	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	0.000158	0.000798	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	0.000156	0.000791	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000156	0.00079	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GAST—pancreatic cancer	0.000156	0.000789	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000154	0.000779	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AGTR1—pancreatic cancer	0.000153	0.000775	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GAST—pancreatic cancer	0.000152	0.000772	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STK11—pancreatic cancer	0.000151	0.000764	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	0.00015	0.000762	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SCT—pancreatic cancer	0.000148	0.000748	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HEY1—pancreatic cancer	0.000148	0.000748	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SCT—pancreatic cancer	0.000145	0.000732	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	0.000145	0.000732	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000142	0.000718	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCK—pancreatic cancer	0.000141	0.000714	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCK—pancreatic cancer	0.000138	0.000698	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GLP1R—pancreatic cancer	0.000137	0.000696	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR2—pancreatic cancer	0.000137	0.000696	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000137	0.000695	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000136	0.000689	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCKAR—pancreatic cancer	0.000135	0.000684	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	0.000134	0.00068	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	0.000134	0.00068	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	0.000134	0.00068	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	0.000132	0.000669	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SMAD4—pancreatic cancer	0.000132	0.000669	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PRSS1—pancreatic cancer	0.000132	0.000667	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JAG2—pancreatic cancer	0.000131	0.000664	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000131	0.000662	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MEN1—pancreatic cancer	0.000129	0.000654	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HES1—pancreatic cancer	0.000129	0.000653	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	0.000128	0.000649	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	0.000126	0.00064	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000124	0.000626	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SHH—pancreatic cancer	0.000123	0.000624	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000122	0.00062	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IAPP—pancreatic cancer	0.000122	0.000616	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SHH—pancreatic cancer	0.000121	0.00061	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	0.00012	0.000607	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	0.000119	0.000603	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000119	0.000601	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTCH1—pancreatic cancer	0.000117	0.000591	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTHLH—pancreatic cancer	0.000117	0.000591	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	0.000114	0.000579	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	0.000114	0.000579	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ARG2—pancreatic cancer	0.000114	0.000578	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TERT—pancreatic cancer	0.000113	0.000572	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HIF1A—pancreatic cancer	0.000108	0.000547	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TSC2—pancreatic cancer	0.000108	0.000546	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SST—pancreatic cancer	0.000107	0.000541	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—APOE—pancreatic cancer	0.000106	0.000534	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000105	0.000534	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JAG1—pancreatic cancer	0.000105	0.000529	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SST—pancreatic cancer	0.000105	0.000529	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000104	0.000527	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KDR—pancreatic cancer	0.000103	0.000523	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000103	0.000522	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	0.000102	0.000518	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000102	0.000516	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TYMP—pancreatic cancer	9.99e-05	0.000506	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CNR1—pancreatic cancer	9.86e-05	0.000499	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKBIA—pancreatic cancer	9.83e-05	0.000498	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NOTCH1—pancreatic cancer	9.74e-05	0.000493	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	9.65e-05	0.000488	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.57e-05	0.000485	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CG—pancreatic cancer	9.52e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—NRAS—pancreatic cancer	9.52e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GCG—pancreatic cancer	9.52e-05	0.000482	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGF—pancreatic cancer	9.41e-05	0.000477	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	9.36e-05	0.000474	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GCG—pancreatic cancer	9.32e-05	0.000472	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.26e-05	0.000469	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AGTR1—pancreatic cancer	9.08e-05	0.00046	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.06e-05	0.000459	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STK11—pancreatic cancer	8.95e-05	0.000453	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	8.89e-05	0.00045	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STK11—pancreatic cancer	8.76e-05	0.000443	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—EGFR—pancreatic cancer	8.68e-05	0.000439	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.41e-05	0.000426	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CD—pancreatic cancer	8.37e-05	0.000424	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.29e-05	0.00042	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	8.23e-05	0.000417	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—KRAS—pancreatic cancer	8.2e-05	0.000415	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.07e-05	0.000409	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GLP1R—pancreatic cancer	8.05e-05	0.000408	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DPYD—pancreatic cancer	7.92e-05	0.000401	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.9e-05	0.0004	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SMAD4—pancreatic cancer	7.84e-05	0.000397	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.76e-05	0.000393	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	7.67e-05	0.000388	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HES1—pancreatic cancer	7.66e-05	0.000388	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	7.59e-05	0.000384	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PIK3CA—pancreatic cancer	7.53e-05	0.000381	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.51e-05	0.00038	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HES1—pancreatic cancer	7.49e-05	0.000379	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.33e-05	0.000371	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CB—pancreatic cancer	7.3e-05	0.00037	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	7.17e-05	0.000363	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—pancreatic cancer	7.05e-05	0.000357	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—pancreatic cancer	7.01e-05	0.000355	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—HRAS—pancreatic cancer	6.97e-05	0.000353	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	6.89e-05	0.000349	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—AKT1—pancreatic cancer	6.77e-05	0.000343	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CASP3—pancreatic cancer	6.71e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TERT—pancreatic cancer	6.71e-05	0.00034	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TERT—pancreatic cancer	6.56e-05	0.000332	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCND1—pancreatic cancer	6.53e-05	0.000331	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CTNNB1—pancreatic cancer	6.47e-05	0.000328	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HIF1A—pancreatic cancer	6.42e-05	0.000325	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TSC2—pancreatic cancer	6.4e-05	0.000324	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—pancreatic cancer	6.34e-05	0.000321	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTEN—pancreatic cancer	6.31e-05	0.000319	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	6.28e-05	0.000318	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—APOE—pancreatic cancer	6.26e-05	0.000317	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	6.26e-05	0.000317	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—AKT1—pancreatic cancer	6.15e-05	0.000312	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KDR—pancreatic cancer	6.14e-05	0.000311	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—APOE—pancreatic cancer	6.13e-05	0.00031	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KDR—pancreatic cancer	6e-05	0.000304	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SRC—pancreatic cancer	5.85e-05	0.000296	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKBIA—pancreatic cancer	5.84e-05	0.000296	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CD44—pancreatic cancer	5.82e-05	0.000295	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NOTCH1—pancreatic cancer	5.78e-05	0.000293	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	5.71e-05	0.000289	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—VEGFA—pancreatic cancer	5.7e-05	0.000288	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	5.65e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CG—pancreatic cancer	5.65e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—NRAS—pancreatic cancer	5.65e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—pancreatic cancer	5.64e-05	0.000286	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NRAS—pancreatic cancer	5.63e-05	0.000285	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGF—pancreatic cancer	5.59e-05	0.000283	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—GCG—pancreatic cancer	5.58e-05	0.000282	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	5.53e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	5.53e-05	0.00028	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGF—pancreatic cancer	5.47e-05	0.000277	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—STK11—pancreatic cancer	5.25e-05	0.000266	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MYC—pancreatic cancer	5.24e-05	0.000265	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—pancreatic cancer	5.23e-05	0.000265	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—EGFR—pancreatic cancer	5.15e-05	0.000261	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—EGFR—pancreatic cancer	5.13e-05	0.00026	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	5.04e-05	0.000255	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CD—pancreatic cancer	4.97e-05	0.000252	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.92e-05	0.000249	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—KRAS—pancreatic cancer	4.87e-05	0.000246	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	4.86e-05	0.000246	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—KRAS—pancreatic cancer	4.84e-05	0.000245	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.81e-05	0.000244	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	4.76e-05	0.000241	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.51e-05	0.000228	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.47e-05	0.000226	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PIK3CA—pancreatic cancer	4.45e-05	0.000225	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	4.37e-05	0.000221	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CB—pancreatic cancer	4.33e-05	0.000219	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TP53—pancreatic cancer	4.3e-05	0.000218	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	4.24e-05	0.000215	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—pancreatic cancer	4.16e-05	0.000211	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—HRAS—pancreatic cancer	4.14e-05	0.000209	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—HRAS—pancreatic cancer	4.12e-05	0.000208	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	4.07e-05	0.000206	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	4.05e-05	0.000205	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—AKT1—pancreatic cancer	4.02e-05	0.000204	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CASP3—pancreatic cancer	3.98e-05	0.000202	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	3.93e-05	0.000199	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	3.9e-05	0.000197	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCND1—pancreatic cancer	3.88e-05	0.000196	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CTNNB1—pancreatic cancer	3.84e-05	0.000194	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	3.79e-05	0.000192	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—pancreatic cancer	3.76e-05	0.000191	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	3.76e-05	0.00019	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTEN—pancreatic cancer	3.74e-05	0.00019	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	3.68e-05	0.000186	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—APOE—pancreatic cancer	3.67e-05	0.000186	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	3.66e-05	0.000185	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—AKT1—pancreatic cancer	3.65e-05	0.000185	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—AKT1—pancreatic cancer	3.63e-05	0.000184	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	3.57e-05	0.000181	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SRC—pancreatic cancer	3.47e-05	0.000176	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SRC—pancreatic cancer	3.4e-05	0.000172	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—VEGFA—pancreatic cancer	3.38e-05	0.000171	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—pancreatic cancer	3.35e-05	0.000169	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NRAS—pancreatic cancer	3.34e-05	0.000169	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.31e-05	0.000168	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	3.31e-05	0.000167	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	3.27e-05	0.000166	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	3.27e-05	0.000165	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.2e-05	0.000162	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MYC—pancreatic cancer	3.11e-05	0.000157	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—pancreatic cancer	3.1e-05	0.000157	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MYC—pancreatic cancer	3.04e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—EGFR—pancreatic cancer	3.04e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	3.04e-05	0.000154	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	2.98e-05	0.000151	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	2.91e-05	0.000147	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—KRAS—pancreatic cancer	2.87e-05	0.000146	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	2.81e-05	0.000142	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PIK3CA—pancreatic cancer	2.64e-05	0.000134	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	2.58e-05	0.000131	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TP53—pancreatic cancer	2.55e-05	0.000129	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.54e-05	0.000128	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.51e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TP53—pancreatic cancer	2.5e-05	0.000127	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—HRAS—pancreatic cancer	2.44e-05	0.000124	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	2.39e-05	0.000121	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.19e-05	0.000111	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—AKT1—pancreatic cancer	2.16e-05	0.000109	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	2.11e-05	0.000107	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.55e-05	7.83e-05	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.26e-05	6.4e-05	CbGpPWpGaD
